Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A First-In-Human, Open-Label, Multicenter Study of VOR33 in Patients With Acute Myeloid Leukemia Who Are at High-Risk for Leukemia Relapse Following Hematopoietic Cell Transplantation

NCT04849910 is registered in ClinicalTrials.gov with Vor Biopharma as lead sponsor.

NCT NCT04849910
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04849910 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A First-In-Human, Open-Label, Multicenter Study of VOR33 in Patients With Acute Myeloid Leukemia Who Are at High-Risk for Leukemia Relapse Following Hematopoietic Cell Transplantation
Lead sponsor
Vor Biopharma
Phase
Phase 1/2
Overall status
Terminated
Start date
December 16, 2021
Completion date
May 28, 2025
Enrollment
67 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, myeloid, acute, myelodysplastic syndromes